Cargando…
Sanfilippo syndrome: causes, consequences, and treatments
Sanfilippo syndrome, or mucopolysaccharidosis (MPS) type III, refers to one of five autosomal recessive, neurodegenerative lysosomal storage disorders (MPS IIIA to MPS IIIE) whose symptoms are caused by the deficiency of enzymes involved exclusively in heparan sulfate degradation. The primary charac...
Autor principal: | Fedele, Anthony O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664539/ https://www.ncbi.nlm.nih.gov/pubmed/26648750 http://dx.doi.org/10.2147/TACG.S57672 |
Ejemplares similares
-
Sanfilippo syndrome: consensus guidelines for clinical care
por: Muschol, Nicole, et al.
Publicado: (2022) -
Mortality in patients with Sanfilippo syndrome
por: Lavery, Christine, et al.
Publicado: (2017) -
Natural history of Sanfilippo syndrome in Spain
por: Delgadillo, Verónica, et al.
Publicado: (2013) -
Sanfilippo Syndrome: Optimizing Care with a Multidisciplinary Approach
por: Cyske, Zuzanna, et al.
Publicado: (2022) -
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
por: Zelei, Tamás, et al.
Publicado: (2018)